Avalo Therapeutics, Inc. ( NASDAQ:AVTX – Get Rating ) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 43,800 shares, a growth of 17.1% from the April 30th total of 37,400 shares. Based on an average trading volume of 48,000 shares, the short-interest ratio is presently 0.9 days. Currently, 0.4% of the company's stock are sold short. Insider Activity at Avalo Therapeutics In other news, major shareholder Caissa Capital Management Ltd. purchased 15,000 shares of Avalo Therapeutics stock in a transaction that occurred on Monday, April 17th.

https://www.dailypolitical.com/2023/05/28/short-interest-in-avalo-therapeutics-inc-nasdaqavtx-rises-by-17-1.html

#dailypolitical